Comorbidities associated with hospitalization and progression among adolescents with symptomatic COVID-19
To identify subgroups likely to benefit from monoclonal antibody and antiviral therapy, we evaluated the relationship between comorbidities and hospitalization among US adolescents with symptomatic COVID-19.
source https://www.jpeds.com/article/S0022-3476(22)00169-X/fulltext?rss=yes
source https://www.jpeds.com/article/S0022-3476(22)00169-X/fulltext?rss=yes
Comments
Post a Comment